Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Powder Formulation of Clopidogrel (Generic Plavix(R)) to Address Gastric Bleeding Risks

January 27, 2026 8:00 AM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today announced the filing of a new provisional patent application with the United States Patent and Trademark Office (USPTO). The application, titled "A Sublingual Powder Formulation of Clopidogrel and Methods of Use Thereof," covers the first-ever sublingual formulation of...

Read more

Who Does the Best Mommy Makeover in Florida?

January 27, 2026 6:00 AM

As mommy makeover procedures nationwide achieve high satisfaction rates, Florida patients are increasingly choosing Dr. Alberico J. Sessa of Sarasota Surgical Arts for comprehensive post-pregnancy restoration.Dr. Sessa, who has successfully completed more than 25,000 surgeries in 18 years of practice, addresses the specific anatomical changes that pregnancy causes: loose abdominal skin from stretched tissue, separated core muscles (diastasis...

Read more

Year-End Report 2025

January 27, 2026 1:45 AM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Fourth quarter 2025 (Oct-Dec)Net sales amounted to SEK 226.1 million (227.6), corresponding to growth of -1 percent in SEK and organic growth of 10 percent in local currencies.Organic growth, excluding revenue from heart trials, was positive at 12 percent in local currencies.The Abdominal business area delivered sales growth of 30 percent in local currencies. Thoracic increased by 9 percent and 12...

Read more

Gianluca Cerri MD Launches a Personal Pledge for Better Emergency Care

January 26, 2026 4:00 PM

Emergency physician Gianluca Cerri MD has announced the launch of a personal pledge focused on improving how emergency care is delivered in high-pressure and resource-limited settings. The pledge is grounded in his day-to-day work in emergency departments, especially rural hospitals, and reflects his long-held belief that better systems-not louder reactions-save lives."For years, I've seen that outcomes improve when teams are prepared before...

Read more

MAGENTIQ EYE Releases New MAGENTIQ-COLO(TM) Versions Expanding User Experience and AI-Based Quality Metrics in Colonoscopy

January 26, 2026 3:45 PM

MAGENTIQ EYE today announced the release of two new versions of MAGENTIQ-COLO™, its AI-powered colonoscopy platform incorporating computer-aided detection (CADe) for real-time polyp detection and computer-aided diagnosis (CADx) capabilities that support polyp size estimation and characterization, designed to deliver consistently higher-quality colonoscopy outcomes.The U.S. version introduces an improved user experience through the addition of an...

Read more

Deepak Dugar, MD Defines a New Standard in Rhinoplasty Practice Rooted in Mastery, Restraint, and Lineage

January 26, 2026 1:45 PM

In an era when aesthetic medicine is increasingly influenced by private equity, volume-driven models, and trend-based outcomes, Dr. Deepak Dugar, double board-certified plastic surgeon and internationally recognized rhinoplasty specialist, announces a formal articulation of his Principles of Practice. These principles define a practice built on mastery, restraint, and surgical lineage rather than scale or persuasion.Dr. Dugar's practice, known...

Read more

The Assistance Fund Opens New Program for Niemann-Pick Disease Type C

January 26, 2026 12:00 PM

The Assistance Fund, an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new financial assistance program for people living with Niemann-Pick disease type C. The program is designed to help eligible individuals pay for their out-of-pocket medical costs for treatment, such as copays, health insurance premiums, and incidental medical...

Read more

Revelation Biosciences Inc. Announces 1-for-4 Reverse Stock Split Effective January 28, 2026

January 26, 2026 9:55 AM

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), announced today that, on January 28, 2026, the Company will implement a 1-for-4 reverse split of its common stock. The reverse stock split will be effective as of the morning of January 28, 2026, and the Company's common stock will trade on a post-split basis at the beginning of trading on the same date under the existing trading symbol "REVB." The CUSIP number for the...

Read more

Canada: Acute Care EHR & Digital Health 2026-What's Changing Now in Adoption, Implementation, Selection and Satisfaction - Black Book Research

January 26, 2026 9:30 AM

Black Book Research today announced the release of its complimentary industry report, Canada Acute Care EHR and Digital Health 2026: Demand Drivers, Pan-Canadian Foundations, Provincial Regulations, and Vendor Landscape, providing a Canada-specific, decision-ready view of the forces reshaping acute care EHR strategy and digital health investment through 2030.The report finds Canada's 2026 acute care EHR and digital health environment is defined...

Read more

Phase 1 Equity Announces Its Second Practice Addition Of The Year, Bringing On A Multi-Site Orthodontic Practice Located in New Jersey

January 26, 2026 9:00 AM

Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for orthodontists and pediatric dentists, is excited to welcome another leading multi-site orthodontic practice based in New Jersey to its growing network.This practice ensures each patient is treated in a comfortable, fun, and effective environment. They offer highly personalized care backed by state-of-the-art technology while delivering exceptional care. This marks Phase...

Read more

Richter Extends Its Support to Africa - The First Year of the House of Hope in Bamako in Numbers

January 26, 2026 8:00 AM

Nearly one year has passed since the House of Hope centre, established by Richter Gedeon Plc., began providing shelter and comprehensive support to women in Bamako. During this period, almost 120 women and girls have benefited from healthcare, legal aid and education. Interest in the centre remains strong, with new women continuously joining the programme. In the coming years, the initiative aims to reach several hundred vulnerable women across...

Read more

Waymark Signal Identifies High-Risk Pregnancies 55 Days Earlier Than Traditional Methods, Study Shows

January 26, 2026 8:00 AM

More than 80% of pregnancy-related deaths are preventable, yet maternal mortality continues to rise in the United States. This is particularly true for people receiving Medicaid benefits, who account for nearly half of all U.S. births and face some of the steepest barriers to early intervention. Current tools used by most healthcare organizations identify risk only after clinical problems appear in claims or electronic health record data,...

Read more

Moderna to Report Fourth Quarter 2025 Financial Results on Friday, February 13, 2026

January 26, 2026 7:00 AM

Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, February 13, 2026 to report its fourth quarter 2025 financial results, and provide a corporate update.A live webcast of the call will be available under "Events and Presentations" in the Investors section of the Moderna website.Webcast: https://investors.modernatx.comThe archived webcast will be available on Moderna's...

Read more

BioNxt Accelerates ODF for Multiple Sclerosis Toward Human Clinical Study with >40% Bioavailability Improvement and Myasthenia Gravis Expansion

January 26, 2026 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce significant progress in the development of its proprietary lead cladribine oral thin film (ODF) program. Recent study results demonstrating a greater than 40% improvement in bioavailability compared to conventional formulations represent a key development milestone and...

Read more

HeyDonto Announces Publication of Core AI Architecture Powering Its Commercial Healthcare Data Platform

January 26, 2026 2:00 AM

HeyDonto today announced the publication of a peer-reviewed research article in Frontiers in Artificial Intelligence describing the core AI architecture that underpins the company's commercial data intelligence platform for healthcare, life sciences, and regulated clinical applications.The article, authored by Dr. Reza Nehzati (Front. Artif. Intell. 8:1689727), presents a biologically inspired framework for self-evolving, self-healing AI systems...

Read more

HepatoBurn Reviews (DOCTOR INVESTIGATES): Does This Liver-Based Fat-Loss Formula Really Work In 2026?

January 25, 2026 7:15 PM

If you've been searching for HepatoBurn reviews in 2026, chances are you've already heard the quiet buzz turning into a roar, not from TikTok trends or social media hype, but from real conversations between doctors, nutritionists, and frustrated individuals who've tried every fat burner on the market with little to no long-term success. What's behind the sudden attention? HepatoBurn isn't just another thermogenic or appetite suppressant. It's...

Read more

IQ Blast Pro Reviews (DOCTOR INVESTIGATES): Can This 2026 Neuro Formula Really Boost Memory, Focus & Brain Energy?

January 25, 2026 1:15 PM

Across the U.S., neurologists are raising alarms about the silent rise of "neural fatigue", a modern epidemic linked to memory lapses, focus problems, and cognitive burnout. In 2025, one supplement called IQ Blast Pro has become the focus of both clinical curiosity and consumer demand. Positioned as a Doctor-Formulated, Stimulant-Free Cognitive Support Formula (Verified), IQ Blast Pro claims to strengthen the brain-blood barrier, what...

Read more

GlucoTrust Bites Reviews (DOCTOR INVESTIAGES) Do These Gluco Trust Gummies Really Support Blood Sugar Balance in 2026?

January 25, 2026 11:26 AM

Blood sugar supplements rarely introduce anything genuinely new. Most rely on familiar capsules, predictable ingredient lists, and surface-level promises that blur together after a while. GlucoTrust Bites arrived with a noticeably different positioning, and that's precisely why searches for GlucoTrust Bites reviews have spiked.Rather than centering solely on insulin output, GlucoTrust Bites focuses on a lesser-discussed metabolic factor:...

Read more

Java Burn Reviews (DOCTOR INVESTIGATES) Why This Coffee-Based Metabolic Formula Is Back Under Investigation

January 24, 2026 6:00 PM

As 2026 begins, Java Burn reviews are once again climbing search results, not because of hype alone, but because coffee-based metabolic supplements are re-entering serious discussion among consumers who want metabolic efficiency without extreme stimulants. Java Burn, a flavorless coffee additive designed to work with caffeine rather than replace it, has resurfaced as one of the most debated formulas in the category. Unlike traditional fat...

Read more

NeuroPrime Reviews (DOCTOR REVEALS) The Real Reason Liquid Brain Supplements Are Replacing Pills in 2026

January 24, 2026 1:35 PM

Most people looking up NeuroPrime reviews in 2026 aren't searching for a long experiment. They want to know one thing: Will I feel something, and how fast? That question exists because the cognitive supplement space has trained consumers to expect either instant stimulation or nothing at all. NeuroPrime enters that conversation differently. Rather than relying on caffeine spikes or synthetic stimulants, NeuroPrime uses a sublingual delivery...

Read more